141 related articles for article (PubMed ID: 37174551)
1. Development of an Inactivated Camelpox Vaccine from Attenuated Camelpox Virus Strain: Safety and Protection in Camels.
Zhugunissov K; Mambetaliyev M; Sarsenkulova N; Tabys S; Kenzhebaeva M; Issimov A; Abduraimov Y
Animals (Basel); 2023 Apr; 13(9):. PubMed ID: 37174551
[TBL] [Abstract][Full Text] [Related]
2. Field Trials of Live and Inactivated Camelpox Vaccines in Kazakhstan.
Mambetaliyev M; Kilibayev S; Kenzhebaeva M; Sarsenkulova N; Tabys S; Valiyeva A; Muzarap D; Tuyskanova M; Myrzakhmetova B; Rametov N; Sarbassova A; Nurgaziev R; Kerimbayev A; Babiuk S; Zhugunissov K
Vaccines (Basel); 2024 Jun; 12(6):. PubMed ID: 38932413
[TBL] [Abstract][Full Text] [Related]
3. Development and Evaluation of a Live Attenuated Egg-Based Camelpox Vaccine.
Zhugunissov K; Kilibayev S; Mambetaliyev M; Zakarya K; Kassenov M; Abduraimov Y; Bulatov Y; Azanbekova M; Absatova Z; Abeuov K; Nurgaziev R; Renukaradhya GJ; Tabynov K
Front Vet Sci; 2021; 8():721023. PubMed ID: 34485443
[TBL] [Abstract][Full Text] [Related]
4. Development and evaluation of a live attenuated camelpox vaccine from a local field isolate of the virus.
Abdellatif MM; Ibrahim AA; Khalafalla AI
Rev Sci Tech; 2014 Dec; 33(3):831-8. PubMed ID: 25812207
[TBL] [Abstract][Full Text] [Related]
5. Attenuation and genetic characteristics of a Moroccan strain of Camel pox virus.
Bamouh Z; Hamdi J; Elkarhat Z; Fellahi S; Omari Tadlaoui K; Watts DM; Fassi Fihri O; Elharrak M
Vaccine; 2022 Oct; 40(45):6471-6480. PubMed ID: 36192275
[TBL] [Abstract][Full Text] [Related]
6. Development of the Inactivated QazCovid-in Vaccine: Protective Efficacy of the Vaccine in Syrian Hamsters.
Zhugunissov K; Zakarya K; Khairullin B; Orynbayev M; Abduraimov Y; Kassenov M; Sultankulova K; Kerimbayev A; Nurabayev S; Myrzakhmetova B; Nakhanov A; Nurpeisova A; Chervyakova O; Assanzhanova N; Burashev Y; Mambetaliyev M; Azanbekova M; Kopeyev S; Kozhabergenov N; Issabek A; Tuyskanova M; Kutumbetov L
Front Microbiol; 2021; 12():720437. PubMed ID: 34646246
[TBL] [Abstract][Full Text] [Related]
7. Development of a live cell culture camelpox vaccine.
Hafez SM; al-Sukayran A; dela Cruz D; Mazloum KS; al-Bokmy AM; al-Mukayel A; Amjad AM
Vaccine; 1992; 10(8):533-9. PubMed ID: 1621417
[TBL] [Abstract][Full Text] [Related]
8. Effects of Three Types of Inactivation Agents on the Antibody Response and Immune Protection of Inactivated IHNV Vaccine in Rainbow Trout.
Tang L; Kang H; Duan K; Guo M; Lian G; Wu Y; Li Y; Gao S; Jiang Y; Yin J; Liu M
Viral Immunol; 2016 Sep; 29(7):430-5. PubMed ID: 27548006
[TBL] [Abstract][Full Text] [Related]
9. Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity.
Budimir N; Huckriede A; Meijerhof T; Boon L; Gostick E; Price DA; Wilschut J; de Haan A
PLoS One; 2012; 7(1):e30898. PubMed ID: 22303469
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of an inactivated, recombinant bovine herpesvirus type 5 (BoHV-5) vaccine.
Campos FS; Dezen D; Antunes DA; Santos HF; Arantes TS; Cenci A; Gomes F; Lima FE; Brito WM; Filho HC; Batista HB; Spilki FR; Franco AC; Rijsewijk FA; Roehe PM
Vet Microbiol; 2011 Feb; 148(1):18-26. PubMed ID: 20828945
[TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of a live attenuated Rift Valley Fever recombinant arMP-12ΔNSm21/384 vaccine candidate for sheep, goats and calves.
Boumart Z; Daouam S; Bamouh Z; Jazouli M; Tadlaoui KO; Dungu B; Bettinger G; Watts DM; Elharrak M
Vaccine; 2019 Mar; 37(12):1642-1650. PubMed ID: 30773401
[TBL] [Abstract][Full Text] [Related]
13. Experimental camelpox infection in vaccinated and unvaccinated dromedaries.
Wernery U; Zachariah R
Zentralbl Veterinarmed B; 1999 Mar; 46(2):131-5. PubMed ID: 10216456
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and protective efficacy in mice and hamsters of a β-propiolactone inactivated whole virus SARS-CoV vaccine.
Roberts A; Lamirande EW; Vogel L; Baras B; Goossens G; Knott I; Chen J; Ward JM; Vassilev V; Subbarao K
Viral Immunol; 2010 Oct; 23(5):509-19. PubMed ID: 20883165
[TBL] [Abstract][Full Text] [Related]
15. Examination of the effects of virus inactivation methods on the induction of antibody- and cell-mediated immune responses against whole inactivated H9N2 avian influenza virus vaccines in chickens.
Astill J; Alkie T; Yitbarek A; Taha-Abdelaziz K; Bavananthasivam J; Nagy É; Petrik JJ; Sharif S
Vaccine; 2018 Jun; 36(27):3908-3916. PubMed ID: 29853199
[TBL] [Abstract][Full Text] [Related]
16. Immunologic evaluation of 10 different adjuvants for use in vaccines for chickens against highly pathogenic avian influenza virus.
Lone NA; Spackman E; Kapczynski D
Vaccine; 2017 Jun; 35(26):3401-3408. PubMed ID: 28511853
[TBL] [Abstract][Full Text] [Related]
17. An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures.
Pereira RC; Silva AN; Souza MC; Silva MV; Neves PP; Silva AA; Matos DD; Herrera MA; Yamamura AM; Freire MS; Gaspar LP; Caride E
Vaccine; 2015 Aug; 33(35):4261-8. PubMed ID: 25862300
[TBL] [Abstract][Full Text] [Related]
18. Improved safety profile of inactivated Neethling strain of the Lumpy Skin Disease Vaccine.
Matsiela MS; Naicker L; Dibakwane VS; Ntombela N; Khoza T; Mokoena N
Vaccine X; 2022 Dec; 12():100209. PubMed ID: 36051749
[TBL] [Abstract][Full Text] [Related]
19. Pathological and molecular investigations of systemic form of camelpox in naturally infected adult male dromedary camels in India.
Narnaware SD; Ranjan R; Dahiya SS; Panchbuddhe A; Bajpai D; Tuteja FC; Sawal RK
Heliyon; 2021 Feb; 7(2):e06186. PubMed ID: 33598582
[TBL] [Abstract][Full Text] [Related]
20. The immunogenicity and protection effect of the BPL-inactivated CA16 vaccine in different animal systems.
Qi An W; Guo Su Z; Wen Pan R; Ping Yang B; Chao Zhang Y; Shi L; Li Q
Hum Vaccin Immunother; 2014; 10(3):628-39. PubMed ID: 24401488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
